Sex (F/M) | 78/245 | 32/62 | 115/0 | 71/19 | |
Age (years) | 33.2 (9.8) | 62.1 (10.0) | 43.9 (13.6) | 35.0 (8.7) | <0.001 |
Time elapsed to first visit (months)† | | 29.8 (22.8) | 21.0 (21.5) | | <0.05 |
FVC (% predicted) | | 61.8 (19.1) | 56.2 (20.3) | | <0.05 |
FEV1 (% predicted) | | 65.6 (18.8) | 59.6 (19.9) | | NS |
FEV1/FVC (%)‡ | | 93.5 (12.5) | 91.8 (8.8) | | NS |
Pao2 (kPa)¶ | | 6.6 (1.5) | 7.1 (1.4) | | <0.01 |
Tlco(%) | | 49.4 (12.2) | 51.7 (18.2) | | NS |
% BAL macrophages | | 77.3 (7.9) | 35.6 (20.2) | | <0.001 |
% BAL lymphocytes | | 17.6 (7.0) | 62.2 (20.7) | | <0.001 |
% BAL neutrophils | | 3.4 (3.7) | 1.4 (2.8) | | <0.01 |
% BAL eosinophils | | 1.7 (2.1) | 0.8 (1.1) | | <0.05 |